Collectively, these findings demonstrate that USP13 and Mcl-1 are concomitantly over expressed in cervical cancer tissue, suggesting that the regulation of Mcl-1 by USP13 is clinically relevant. This evidence concerns the gene USP13 and cervical cancer.